Cronos Group
CRON • NASDAQ • Stock Fundamentals
Cronos Group is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Michael Ryan Gorenstein, with a market cap of $1.0B.
Market Cap$1.0B
Employees356.0
CEOMichael Ryan Gorenstein
CountryCanada
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Cronos Group FAQ
Common questions about Cronos Group
Cronos Group (CRON) has a market capitalization of $1.0B and trades on NASDAQ.
Cronos Group has approximately 356 employees.